UK shareholder meetings calendar - next 7 days
22nd Jan 2026 17:13
| Price | 11.00p on 10-02-2026 at 17:40:05 |
|---|---|
| Change | 0.80p 7.34% |
| Buy | 12.00p |
| Sell | 10.00p |
| Last Trade: | Buy 12,700.00 at 11.70p |
| Day's Volume: | 96,423 |
| Last Close: | 11.70p |
| Open: | 11.10p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 11.00p - 11.90p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £718.55m |
| VWAP: | 11.16327p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 12,700 | 11.70p | Ordinary |
16:35:50 - 10-Feb-26 |
| Sell* | 5,752 | 10.00p | Ordinary |
14:20:41 - 10-Feb-26 |
| Buy* | 5,752 | 12.00p | Ordinary |
14:03:15 - 10-Feb-26 |
| Sell* | 7,670 | 10.00p | Ordinary |
14:01:39 - 10-Feb-26 |
| Buy* | 3,500 | 11.90p | Suspected BUY Trade |
14:00:28 - 10-Feb-26 |
| Buy* | 30 | 12.00p | SI Trade |
12:43:44 - 10-Feb-26 |
| Buy* | 100 | 12.00p | SI Trade |
12:43:44 - 10-Feb-26 |
| Sell* | 18,368 | 10.888p | Ordinary |
12:13:13 - 10-Feb-26 |
| Sell* | 5,000 | 10.38p | Ordinary |
11:13:51 - 10-Feb-26 |
| Sell* | 808 | 10.888p | Ordinary |
11:12:07 - 10-Feb-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jan 2026 8:22 am | RNS | Chief Strategy Officer and Board appointments |
| 29th Jan 2026 2:13 pm | RNS | Result of Annual General Meeting |
| 28th Jan 2026 4:48 pm | RNS | Grant of Options under Long Term Incentive Scheme |
| 19th Jan 2026 7:00 am | RNS | Half Year Trading Update |
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |